Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-03

Clinical Trial Update: Ketamine and Refractory Painful Care in a Palliative Unit [Phase 4]

View source ↗

Summary

Phase 4 trial update on ketamine for refractory pain in a palliative care setting; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Lille Catholic University | Conditions: Intractable Pain, Intensive Care | Phase 4 | Status: TERMINATED